ChrysCapital Buys Novartis AG’s 70.68% Stake In Novartis India
ChrysCapital is acquiring the full 70.68% stake in Novartis India Ltd from Novartis AG for ₹1,446 crore. Novartis India will be renamed with a new corporate identity and management team, marking separation from its previous owner while keeping legacy brands. About 40 employees are expected to transfer as operations are rebuilt via existing contract manufacturing relationships.